...
首页> 外文期刊>Circulation journal >Clinical Impact of New-Onset Left Bundle-Branch Block After Transcatheter Aortic Valve Implantation in the Japanese Population ― A Single High-Volume Center Experience ―
【24h】

Clinical Impact of New-Onset Left Bundle-Branch Block After Transcatheter Aortic Valve Implantation in the Japanese Population ― A Single High-Volume Center Experience ―

机译:新发起左束块临床影响在日本人口经沟管主动脉瓣植入后的经沟管主动脉瓣植入 - 单一高批量中心体验 -

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Although left bundle-branch block (LBBB) is a known conduction disorder that occurs after transcatheter aortic valve implantation (TAVI), its clinical impact in the Japanese population remains unclear. Methods?and?Results: Of the 298 consecutive patients who underwent TAVI from January 2016 to December 2018 in a high-volume center in Japan, 68 with prior or periprocedural permanent pacemaker implantation (PPI), pre-existing LBBB, death during hospitalization, aborted procedure, or incomplete data were excluded. Among the final cohort of 230 patients, new-onset LBBB occurred in 90 (39%) after TAVI and persisted at 1-month follow up in 29 patients (13%; persistent new-onset LBBB, PN-LBBB). On multivariable analysis, self-expandable valve (SEV) use was found to be the only predictor of PN-LBBB (odds ratio: 4.39, 95% confidence interval: 1.69–11.41, P=0.002). There were no differences between patients with and without PN-LBBB in terms of overall mortality (18.8% vs. 26.0%, log-rank P=0.90) or need for late PPI (4.0% vs. 3.5%, log-rank P=0.74), yet there was an increased re-admission rate for heart failure (HF) in the PN-LBBB group (15.6% vs. 8.0%, log-rank P=0.046) at a median follow up of 431 (interquartile range, 271–733) days. Conclusions: PN-LBBB following TAVI was not associated with mortality or late PPI, but with a higher incidence of HF-related re-hospitalization at the mid-term follow up.
机译:背景:虽然左束支链块(LBBB)是经经沟管主动脉瓣植入(Tavi)后发生的已知导通障碍,但其在日本人群中的临床影响尚不清楚。方法?结果:在2016年1月至2018年12月在日本的大批量中心完成Tavi的298名连续患者,68名与先前的或百倍的永久性起搏器植入(PPI),预先存在的LBBB,住院期间死亡,中流程或不完整的数据被排除在外。在230名患者的最终队列中,Tavi后90(39%)发生新的发病LBBB,并在29名患者的1个月内持续后持续(13%;持久性新发作LBBB,PN-LBBB)。在多变量分析中,发现自膨胀阀(SEV)使用是PN-LBBB的唯一预测因子​​(差距比率:4.39,95%置信区间:1.69-11.41,P = 0.002)。在总体死亡率方面没有PN-LBBB(18.8%,对数级别P = 0.90)或需要晚期PPI(4.0%与3.5%,LOG-RANK P =之间没有差异0.74),但在431(间隔率范围)的中位数,PN-LBBB组心力衰竭(HF)的再入入率增加了(15.6%,LOG-RANK P = 0.046) 271-733)天。结论Tavi后PN-LBBB与死亡率或晚期PPI无关,但在中期跟进中具有较高的HF相关再住院治疗发病率。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号